SCHEMBL15098147

SCHEMBL15098147

CCCn1c(C(=O)Cl)cc2ccsc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.43
RCOR1 Q9UKL0 2/20 0.43
L3MBTL1 Q9Y468 4/20 0.43
LMNA P02545 3/20 0.43
TSHR P16473 8/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
MAPT P10636 3/20 0.42
TP53 P04637 1/20 0.42
ALDH1A1 P00352 6/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
USP2 O75604 3/20 0.40
ESR1 P03372 1/20 0.40
HPGD P15428 3/20 0.37
RECQL P46063 3/20 0.36
POLB P06746 2/20 0.36
KDM4E B2RXH2 2/20 0.36
HSD17B10 Q99714 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2331226 0.87 KDM1A (0.47) KDM1ARCOR1L3MBTL1LMNATSHR
SCHEMBL12444183 0.85 KDM1A (0.43) KDM1ARCOR1L3MBTL1LMNATSHR
SCHEMBL2330694 0.83 L3MBTL1 (0.61) KDM1ARCOR1L3MBTL1LMNATSHR
SCHEMBL15097995 0.77 CNR2 (0.42) KDM1ARCOR1L3MBTL1LMNATSHR
SCHEMBL12443332 0.74 CNR2 (0.58) LMNATSHRMAPTALDH1A1MEN1
SCHEMBL2330722 0.74 GPR35 (0.50) KDM1ARCOR1L3MBTL1LMNATSHR
SCHEMBL15097977 0.73 CNR2 (0.49) LMNATSHRMAPTALDH1A1MEN1
SCHEMBL15097997 0.73 TSHR (0.36) KDM1ARCOR1L3MBTL1LMNATSHR
SCHEMBL12443718 0.72 CNR2 (0.56)
SCHEMBL12443764 0.72 GPR84 (0.46) LMNASMN1; SMN2MAPTTP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130178453-A1 Cannabinoid Agonists IRONWOOD PHARMACEUTICALS, INC. (US) 2013-07-11 US disclosed
US-20130178453-A1 Cannabinoid Agonists IRONWOOD PHARMACEUTICALS, INC. (US) 2013-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178453-A1 Cannabinoid Agonists CNR2, CNR1, GPR18 KDM1A 2559/4885RCOR1 3023/4885L3MBTL1 4751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.